{
    "organizations": [],
    "uuid": "36c30fc376d73380492d6fb0b6deb04a5e2ed418",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-paradigm-biopharmaceuticals-says-e/brief-paradigm-biopharmaceuticals-says-european-patent-granted-for-treatment-of-bone-marrow-edema-lesions-idUSFWN1PA0IW",
    "ord_in_thread": 0,
    "title": "BRIEF-Paradigm Biopharmaceuticals ‍Says European Patent Granted For Treatment Of Bone Marrow Edema Lesions",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 16 (Reuters) - Paradigm Biopharmaceuticals Ltd:\n* ‍GRANTED EUROPEAN PATENT FOR TREATMENT OF BONE MARROW EDEMA LESIONS WITH PENTOSAN POLYSULFATE SODIUM​ Source text for Eikon: Further company coverage:\n ",
    "published": "2018-01-16T05:55:00.000+02:00",
    "crawled": "2018-01-16T13:39:15.000+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "paradigm",
        "biopharmaceuticals",
        "ltd",
        "european",
        "patent",
        "treatment",
        "bone",
        "marrow",
        "edema",
        "lesion",
        "pentosan",
        "polysulfate",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}